Esa Leìnonen

5.6k total citations
161 papers, 3.6k citations indexed

About

Esa Leìnonen is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Esa Leìnonen has authored 161 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Psychiatry and Mental health, 47 papers in Pharmacology and 28 papers in Clinical Psychology. Recurrent topics in Esa Leìnonen's work include Bipolar Disorder and Treatment (49 papers), Electroconvulsive Therapy Studies (46 papers) and Treatment of Major Depression (46 papers). Esa Leìnonen is often cited by papers focused on Bipolar Disorder and Treatment (49 papers), Electroconvulsive Therapy Studies (46 papers) and Treatment of Major Depression (46 papers). Esa Leìnonen collaborates with scholars based in Finland, Sweden and United States. Esa Leìnonen's co-authors include Sami Anttila, Olli Kampman, Ulla Lepola, Terho Lehtimäki, Hannu Koponen, Ari Illi, Merja Viikki, Martti Huuhka, Kari M. Mattila and Nina Mononen and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Esa Leìnonen

155 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Esa Leìnonen 1.7k 1000 661 622 548 161 3.6k
Diana De Ronchi 1.1k 0.7× 856 0.9× 848 1.3× 732 1.2× 600 1.1× 157 3.9k
Otto Benkert 1.8k 1.1× 1.1k 1.1× 579 0.9× 737 1.2× 383 0.7× 193 3.9k
Gonzalo Laje 1.6k 0.9× 929 0.9× 639 1.0× 955 1.5× 732 1.3× 39 3.6k
Armin Szegedi 2.3k 1.3× 1.3k 1.3× 696 1.1× 537 0.9× 407 0.7× 120 4.6k
J. Craig Nelson 1.4k 0.8× 1.2k 1.2× 522 0.8× 493 0.8× 563 1.0× 55 3.4k
A. Carlo Altamura 2.9k 1.7× 975 1.0× 422 0.6× 1.3k 2.1× 616 1.1× 173 5.2k
Chiara Fabbri 1.0k 0.6× 1.2k 1.2× 489 0.7× 350 0.6× 900 1.6× 155 3.1k
Richard C. Shelton 905 0.5× 1.5k 1.5× 818 1.2× 549 0.9× 1.1k 2.1× 65 3.9k
J. Craig Nelson 1.4k 0.8× 1.3k 1.3× 310 0.5× 496 0.8× 476 0.9× 87 3.2k
Keming Gao 2.3k 1.4× 703 0.7× 505 0.8× 633 1.0× 600 1.1× 138 4.8k

Countries citing papers authored by Esa Leìnonen

Since Specialization
Citations

This map shows the geographic impact of Esa Leìnonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esa Leìnonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esa Leìnonen more than expected).

Fields of papers citing papers by Esa Leìnonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esa Leìnonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esa Leìnonen. The network helps show where Esa Leìnonen may publish in the future.

Co-authorship network of co-authors of Esa Leìnonen

This figure shows the co-authorship network connecting the top 25 collaborators of Esa Leìnonen. A scholar is included among the top collaborators of Esa Leìnonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esa Leìnonen. Esa Leìnonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solismaa, Anssi, et al.. (2023). Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of Psychopharmacology. 37(2). 229–233. 2 indexed citations
2.
Järventausta, Kaija, Olli Kampman, Kai Lehtimäki, et al.. (2021). Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder. Brain and Behavior. 11(8). e02001–e02001. 8 indexed citations
3.
Isohanni, Matti, et al.. (2020). Antipsychotics in late-life schizophrenia - a narrative review. SHILAP Revista de lepidopterología.
4.
Pitkänen, Anneli, et al.. (2019). Implementing physical exercise and music interventions for patients suffering from dementia on an acute psychogeriatric inpatient ward. Nordic Journal of Psychiatry. 73(7). 401–408. 15 indexed citations
5.
Niemelä, Onni, et al.. (2019). Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder. Alcohol. 81. 21–26. 7 indexed citations
6.
Järventausta, Kaija, Olli Kampman, Kai Lehtimäki, et al.. (2018). Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder. Brain and Behavior. 8(11). e01101–e01101. 17 indexed citations
7.
Kampman, Olli, Merja Viikki, Eija Setälä-Soikkeli, et al.. (2018). BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression. Acta Neuropsychiatrica. 30(3). 168–174. 3 indexed citations
8.
Järventausta, Kaija, Olli Kampman, Mari Hämäläinen, et al.. (2016). Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatrica Scandinavica. 135(1). 87–92. 53 indexed citations
9.
Solismaa, Anssi, Olli Kampman, Niko Seppälä, et al.. (2014). Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment. Human Psychopharmacology Clinical and Experimental. 29(4). 336–341. 16 indexed citations
10.
Illi, Ari, Merja Viikki, Outi Poutanen, et al.. (2012). No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatric Genetics. 23(1). 33–35. 14 indexed citations
11.
Viikki, Merja, Olli Kampman, Sami Anttila, et al.. (2011). P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neuroscience Letters. 493(3). 127–130. 37 indexed citations
12.
Viikki, Merja, Kaija Huuhka, Esa Leìnonen, et al.. (2011). Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD. Neuroscience Letters. 501(1). 20–24. 22 indexed citations
13.
Kampman, Olli, Outi Poutanen, Ari Illi, et al.. (2010). Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. European Psychiatry. 27(4). 245–249. 27 indexed citations
14.
Palmio, Johanna, Martti Huuhka, Seppo Laine, et al.. (2010). Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein. Psychiatry Research. 177(1-2). 97–100. 39 indexed citations
15.
Huuhka, Kaija, Sami Anttila, Martti Huuhka, et al.. (2008). Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neuroscience Letters. 448(1). 79–83. 40 indexed citations
16.
Anttila, Sami, Kaija Huuhka, Martti Huuhka, et al.. (2007). Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. The Pharmacogenomics Journal. 8(2). 113–116. 25 indexed citations
17.
Huuhka, Kaija, Martti Huuhka, Riikka Rontu, et al.. (2006). Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. Journal of Neural Transmission. 114(4). 461–468. 24 indexed citations
18.
Palmio, Johanna, Martti Huuhka, Pirjo Saransaari, et al.. (2005). Changes in plasma amino acids after electroconvulsive therapy of depressed patients. Psychiatry Research. 137(3). 183–190. 35 indexed citations
19.
Huuhka, Martti, et al.. (2004). One-Year Outcome of Elderly Inpatients With Major Depressive Disorder Treated With ECT and Antidepressants. Journal of Ect. 20(3). 179–185. 11 indexed citations
20.
Koponen, Hannu, Esa Leìnonen, & Ulla Lepola. (1996). Fluvoxamine increases the clozapine serum levels significantly. European Neuropsychopharmacology. 6(1). 69–71. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana De Ronchi Breakdown of academic impact, for papers by Otto Benkert Breakdown of academic impact, for papers by Gonzalo Laje Breakdown of academic impact, for papers by Armin Szegedi Breakdown of academic impact, for papers by J. Craig Nelson Breakdown of academic impact, for papers by A. Carlo Altamura Breakdown of academic impact, for papers by Chiara Fabbri Breakdown of academic impact, for papers by Richard C. Shelton Breakdown of academic impact, for papers by J. Craig Nelson Breakdown of academic impact, for papers by Keming Gao
Rankless by CCL
2026